Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results

Rhea-AI Summary

Prestige Consumer Healthcare (NYSE: PBH) will release its fiscal 2021 first quarter earnings on August 6, 2020, before market opening. The company will host a conference call to discuss the results at 8:30 a.m. ET on the same day, accessible via phone for U.S. and Canadian listeners at 844-233-9440 or 574-990-1016 internationally. A live webcast will be available on the Investor Relations page of the company’s website. Replay options will also be offered for one week post-call.

TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August 6, 2020 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 4482198. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.

Telephonic replays will be available for approximately one week following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America. The conference ID is 4482198.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact

Phil Terpolilli, CFA, 914-524-6819

irinquiries@prestigebrands.com

FAQ

When will Prestige Consumer Healthcare announce its fiscal 2021 first quarter earnings?

Prestige Consumer Healthcare will announce its fiscal 2021 first quarter earnings on August 6, 2020.

What time is the earnings conference call for PBH?

The earnings conference call for PBH is scheduled for 8:30 a.m. ET on August 6, 2020.

How can I access the earnings call for Prestige Consumer Healthcare?

You can access the earnings call by dialing 844-233-9440 from the U.S. and Canada, or 574-990-1016 internationally, using conference ID 4482198.

Will there be a replay of the earnings conference call for PBH?

Yes, telephonic replays will be available for approximately one week after the live call at 855-859-2056 within North America and 404-537-3406 from outside North America.